Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Originator

Ragozzino, D. et al.

1

Pfizer

420

Eli Lilly

239

Merck

238

GlaxoSmithKline

197

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

Other

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

GABA-C receptor

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Retinitis pigmentosa

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

1

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

1

EPA CompTox

1

FDA UNII

1

MERCK INDEX

1

PUBCHEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

TPMPA

TR7I0800L2

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

GABA-C receptor

Conditions:

Retinitis pigmentosa

(1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid (TPMPA) is a competitive antagonist of gamma-aminobutyric acid (GABA)C receptors.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1